Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.

@article{Dukov2010ChangesOM,
  title={Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.},
  author={Michaela Du{\vs}kov{\'a} and Martin Hill and Luboslav St{\'a}rka},
  journal={Endocrine regulations},
  year={2010},
  volume={44 1},
  pages={3-8}
}
OBJECTIVE Androgenetic alopecia is recognized as a risk factor for cardiovascular diseases, glucose metabolism disorders, and benign prostate hyperplasia and/or carcinoma. Finasteride, used for treatment of androgenetic alopecia at a dose of 1mg/day, is an effective inhibitor of type II 5alpha-reductase, the enzyme responsible for the reduction of testosterone to dihydrotestosterone. Recent studies reported that dihydrotestosterone, among other activities, might play some role in visceral fat… CONTINUE READING